BEYFORTUS sol inj 50 mg/0.5ml 2 aiguilles ser pré
7680690390020
CH-69039
J06BD08
08.03.0.
Reimbursement limitations:
BEYFORTUS
La prise en charge des coûts de l’anticorps monoclonal pour la prophylaxie du VRS au …
1 / 3
google
Details
- Product number
- 6903901
- CPT
- -
- Packaging group
- 1
- Unit
- Fertigspritze(n)
- Composition
- nirsevimabum 50 mg, histidinum, histidini hydrochloridum monohydricum, arginini hydrochloridum, saccharum, polysorbatum 80, aqua ad iniectabile ad solutionem pro 0.5 ml.
Articles (1)
Beyfortus 50 mg/0.5 ml, solution injectable en seringue préremplie
Lösung
1
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
(N/A)
|
50.0 MG | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
Reimbursement information
Public price
CHF 395.40
Specialties list
Yes
Generic
No
Reimbursement limitation
SL addition date:
01/09/2024
Authorization holder
Sanofi-Aventis (Suisse) SA
1214 Vernier
Authorization information
- Swissmedic authorization number
- 69039
- Drug name
- Beyfortus, solution injectable en seringue préremplie
- Galenic form
- INLFS
- ATC Code
- J06BD08
- Authorization status
- Z
- Dispensation category
- A
- First authorization
- 22/12/2023
- Authorization expiration date
- 21/12/2028
- IT number
- 08.03.0.
- Domain
- Human medicine
Packaging details
- Description (FR)
- BEYFORTUS sol inj 50 mg/0.5ml 2 aiguilles ser pré
- Description (DE)
- BEYFORTUS Inj Lös 50 mg/0.5ml 2 Nadeln Fertspr
- Market launch
- 22/12/2023
- Narcotic (BTM)
- No